Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


A study to investigate the effects of repeated low doses of psilocybin and ketamine on cognitive and emotional dysfunctions in Parkinson’s disease and to understand its mechanism of action


To see complete record on www.clinicaltrialsregister.eu, please visit this link

Id: 2021-000041-40

Organisation Name: Maastricht University

Start Date: 2021-11-10

Completion Date: Ongoing

Brief Summary: The main objective is to investigate the effects of repeated small doses of psilocybin and ketamine on affect (self-rated).

Country: Netherlands



Total execution time in seconds: 0.12625503540039